What's new in WHO fifth edition – Urinary tract Review


Authors: Compérat, E.; Amin, M. B.; Berney, D. M.; Cree, I.; Menon, S.; Moch, H.; Netto, G. J.; Rao, V.; Raspollini, M. R.; Rubin, M. A.; Srigley, J. R.; Tan, P. H.; Tickoo, S. K.; Turajlic, S.; Tsuzuki, T.
Review Title: What's new in WHO fifth edition – Urinary tract
Abstract: The fifth edition of the WHO Blue Book on urological tumours, specifically in the bladder chapter, represents a refinement and update in the classification of bladder tumours building on the aggregate major changes made in previous editions. Progress in the molecular underpinnings of urothelial tumours, particularly with promising stratifiers for more precision-based treatment approaches, have been made. Special attention has been paid to burning questions in bladder pathology, such as grading, heterogeneous lesions, inverted tumours and substaging. The concept of neuroendocrine tumours will be explained precisely. © 2022 John Wiley & Sons Ltd.
Keywords: review; cancer staging; staging; cytology; pathology; bladder cancer; bladder tumor; urinary bladder neoplasms; urologic neoplasms; world health organization; nomenclature; urinary tract; molecular diagnosis; urinary tract tumor; humans; human; molecular stratification; heterogenous tumours; inverted lesions
Journal Title: Histopathology
Volume: 81
Issue: 4
ISSN: 0309-0167
Publisher: Wiley Blackwell  
Date Published: 2022-10-01
Start Page: 439
End Page: 446
Language: English
DOI: 10.1111/his.14764
PUBMED: 35942645
PROVIDER: scopus
DOI/URL:
Notes: Published within a special edition on WHO 2022 classification of urinary and male genital tumours -- Export Date: 3 October 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Satish K Tickoo
    483 Tickoo